Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA
Immunotherapy is an emerging field in medicine using the body's immune to combat various diseases, particularly cancer. In recent years, several immunotherapy agents have obtained regulatory approval from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for th...
Saved in:
| Main Authors: | Maryam Monajati, Alimohammad Tamaddon, Samira Sadat Abolmaali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2024-09-01
|
| Series: | Trends in Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://tips.sums.ac.ir/article_50352_5b87c1b5bbb0aa35cd5a7de2006ac35b.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current and future immunotherapy for breast cancer
by: Natalie K. Heater, et al.
Published: (2024-12-01) -
Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01) -
Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
by: Emily Wolf, et al.
Published: (2025-01-01) -
Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches
by: Sherif A. El-Kafrawy, et al.
Published: (2025-06-01) -
Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis
by: Jinqiao Li, et al.
Published: (2024-12-01)